Partial Prostate Salvage High Dose Rate Brachytherapy (NCT03246802)
High Dose Rate Partial Prostate Brachytherapy as Salvage Treatment for Local Failures After Previous External Beam Radiotherapy
🩺 Plain-English Summary (8th-Grade Level)
A dose-response relationship for radiation in the management of prostate cancer is well established. Local recurrence of prostate cancer after external beam radiotherapy occurs in at least 40% of patients treated because of inability to deliver sufficient dose through external beam techniques. These patients respond well to re-irradiation using brachytherapy with about 50% of selected patients remaining free of recurrence 5 years after salvage. Advanced imaging using multiparametric Magnetic Resonance Imaging (mpMRI) allows identification of the site of recurrence, permitting partial prostate salvage brachytherapy. There is extensive literature on Low Dose Rate salvage brachytherapy but less on High Dose Rate.
Who can join: Review the eligibility criteria below.
Location: BCCA Center for the Southern Interior — Kelowna, British Columbia
Age range: 45 Years
🧪 Interventions in This Study
- HDR partial prostate brachytherapy (RADIATION)
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- BCCA Center for the Southern Interior — Kelowna, British Columbia
📞 Contact the Study Coordinator
Phone: (250) 712-3958
Email: jcrook@bccancer.bc.ca
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Recurrent Prostate Cancer
- Study of ADXS-504 Immunotherapy for Recurrent Prostate Cancer — New York, New York
- Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer After Undergoing Surgery — Duarte, California
- Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients — San Francisco, California
- IL-15 Superagonist With or Without Vaccine in Biochemically Recurrent Prostate Cancer After Previous Stereotactic Body Radiation Therapy — Bethesda, Maryland
- Tumor Microenvironment Analysis of Prostate Cancer Metastasis — New York, New York
- Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System — New York, New York
Explore by condition: All Recurrent Prostate Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.